Moneycontrol
HomeNewsTrendsHealthActive COVID-19 caseload rises in India first time in 80 days amid uptick in daily cases in some states
Trending Topics

Active COVID-19 caseload rises in India first time in 80 days amid uptick in daily cases in some states

Active COVID-19 cases in India have increased by 818 in the 24-hour period.

April 14, 2022 / 10:33 IST
Story continues below Advertisement
Representative image (REUTERS/Danish Siddiqui)

India, on April 14, registered a rise in active COVID-19 caseload for the first time in 80 days as active cases increased from 10,870 to 11,058 in the 24-hour period.

As the country reported 1,007 daily new coronavirus cases it was also the second day in a row that fresh infections in a 24-hour period were above 1,000. The fresh tally of COVID-19 cases takes the total confirmed infections to 4,30,39,023.

Story continues below Advertisement

The rise in active COVID-19 cases meanwhile comes amid an uptick in new cases and test positivity rates in at least three States-Delhi, Guajarat and Haryana. Many hospitals and doctors in these states also confirmed that there has been a rise in patients visiting OPDs with COVID-19 symptoms.

They however also say that the majority of the patients are mildly symptomatic with fever, cold and cough and do not need hospitalisation.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show